Home » Topics » BioWorld Science

BioWorld Science
RSS

Cathepsin L inhibitors with broad therapeutic potential from Takeda

Nov. 27, 1997

WB-2663B, a novel immunosuppressant isolated from Pseudomonas

Nov. 27, 1997

Agents activating beta3-adrenoceptors from Pfizer

Nov. 27, 1997

New V1 antagonists disclosed by Yamanouchi

Nov. 27, 1997

AnorMED's AMD-473 enters phase I

Nov. 27, 1997

Ono's elastase inhibitor poised to enter phase I in Europe

Nov. 27, 1997

Beaufour-Ipsen moves TH-9506 to phase I

Nov. 27, 1997

Stress proteins shown to activate CTL response to cancer cells

Nov. 27, 1997

Ono accelerates overseas development of neurologic drug

Nov. 27, 1997

Cephalon and TAP renew oncology collaboration

Nov. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...